COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,760 Articles (22,502 medRxiv, 8,258 bioRxiv)

Most recent first Previous |  Page 1008: Articles 10071-10080  | Next

A third vaccination with a single T cell epitope protects against SARS-CoV-2 infection in the absence of neutralizing antibodies
Pardieck, I. N., van der Gracht, E. T. I., Veerkamp, D. M. B., Behr, F. M., van Duikeren, S., Beyrend, G., Rip, J., Nadafi, R., van der Sluis, T. C., Beyranvand Nejad, E., Mulling, N., Brasem, D. J., Camps, M. G. M., Myeni, S. K., Bredenbeek, P. J., Kikkert, M., Kim, Y., Cicin-Sain, L., Abdelaal, T., van Gisbergen, K. P. J. M., Franken, K. L. M. C., Drijfhout, J. W., Melief, C. J. M., Zondag, G. C. M., Ossendorp, F., Arens, R.
10.1101/2021.12.15.472838 — Posted: 2021-12-18
Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
Zhang, A., Breznik, J. A., Clare, R., Nazy, I., Miller, M. S., Bowdish, D. M. E., Costa, A. P., COVID-in-LTC Study Group
10.1101/2021.12.17.21267996 — Posted: 2021-12-18
Pseudotyped SARS-CoV-2 Omicron variant exhibits significant escape from neutralization induced by a third booster dose of vaccination
Yu, X., Wei, D., Xu, W., Li, Y., Li, X., Zhang, X.-x., Qu, J., Yang, Z., Chen, E.
10.1101/2021.12.17.21267961 — Posted: 2021-12-18
Vaccine efficacy for COVID-19 outbreak in New York City
Demongeot, J., Griette, q., magal, p., Webb, G.
10.1101/2021.12.18.21268024 — Posted: 2021-12-18
Resource Profile: The Regenstrief Institute COVID-19 Research Data Commons (CoRDaCo)
Allen, K. S., Zidan, N., Dey, V., Mendonca, E., Grannis, S., Kasturi, S., Khan, B., Zappone, S. R., Haggstrom, D., Ruppert, L., Schleyer, T., Ning, X., Embi, P., Tachinardi, U.
10.1101/2021.12.17.21267942 — Posted: 2021-12-18
Provider Confidence in Counseling Preconception, Pregnant, and Postpartum Patients Regarding COVID-19 Vaccination
Siegel, M. R., James, K. E., Jaffe, E., L'Heureux, M. M., Kaimal, A. J., Goldfarb, I. T.
10.1101/2021.12.17.21267998 — Posted: 2021-12-18
Perceptions and Attitudes Towards COVID-19 Vaccination Amongst Pregnant and Postpartum Individuals
Siegel, M. R., Lumbreras-Marquez, M. I., James, K., McBay, B. R., Gray, K. J., Schantz-Dunn, J., Diouf, K., Goldfarb, I. T.
10.1101/2021.12.17.21267997 — Posted: 2021-12-18
Syndromic Surveillance-Based Estimates of Vaccine Efficacy Against COVID-Like Illness from Emerging Omicron and COVID-19 Variants
Varrelman, T. J., Rader, B. M., Astley, C. M., Brownstein, J. S.
10.1101/2021.12.17.21267995 — Posted: 2021-12-18
Amyloidogenesis of SARS-CoV-2 Spike Protein
Nystrom, S., Hammarstrom, P.
10.1101/2021.12.16.472920 — Posted: 2021-12-17
Presentation, characteristics, treatments and outcomes of mechanically ventilated patients with COVID-19 in Bulgaria
Bakalova, N., Natsev, I., Damov, H., Yatsenko, I., Jovinska, S., Enev, R., Cholakov, M., Abedinov, F., Kalendjieva, D.
10.1101/2021.12.17.21267655 — Posted: 2021-12-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).